Conduce Health is a technology company.
Conduce Health has raised $3.0M across 1 funding round.
Conduce Health has raised $3.0M in total across 1 funding round.
Conduce Health has raised $3.0M in total across 1 funding round.
Conduce Health's investors include Commerce Ventures, Connecticut Innovations, Convective Capital, Healthy Ventures, TY.
Conduce Health is a healthcare technology company that built an AI-driven platform for multi-specialty value-based care, predicting patient needs, matching patients to optimal specialists, and optimizing specialty care networks to reduce costs and improve outcomes.[1][4][5] It served primary care organizations, health plans, REACH & MSSP ACOs, health systems, and value-based MSOs by addressing fragmented referrals, specialist shortages, and inefficient risk management in chronic disease care for elderly patients.[1][5][6] The platform solved key problems like disorganized specialty options, lack of real-time insights into specialist quality and costs, and challenges in making specialty care value-based, using proprietary clinical profiles, predictive algorithms, and streamlined contracting.[1][2][5]
Launched from stealth in March 2024 with a network of over 150 specialty physicians, Conduce quickly gained traction through its data science approach but was acquired by Switchboard Health in September 2025, integrating its AI capabilities into a larger specialty care platform.[1][2][3] This move expanded its growth momentum by combining with Switchboard's EMR-integrated tools and virtual care network, enhancing precision matching for disease progression and urgent needs.[2][3]
Conduce Health was founded in 2023 by an experienced team of health tech entrepreneurs and physicians, including co-founder and CEO Najib Jai, MD, and Dr. Jeff De Flavio (also referred to as Dr. De Flavio), who served as co-founder, Executive Chairman, and later Board Chair.[1][2][3][4] Backed by AlleyCorp, the company emerged to tackle the integration of multi-specialty care into value-based models, focusing on sicker patients with chronic conditions amid specialist shortages.[2][3][4][6]
The idea stemmed from the need for tools that predict patient needs, match them to the right specialists, and optimize networks, born out of clinicians' frustrations with population health shifts toward accountability.[1][4][6] It launched publicly in March 2024 as a turnkey marketplace, boasting early traction with 150+ physicians and proprietary AI for clinical profiles and referrals.[1] A pivotal moment came with its acquisition by Switchboard Health on September 30, 2025, where key team members joined to scale the technology.[2][3]
Conduce stood out in value-based specialty care through these key features:
These elements made specialty care proactive, personalized, and scalable, differentiating from siloed solutions.[4][6]
Conduce rode the value-based care wave, accelerating the shift from fee-for-service to risk-bearing models amid rising chronic disease prevalence and specialist shortages.[1][5][6] Its timing aligned with healthcare's "tectonic shift" to accountability, where AI bridges primary-to-specialty gaps, reduces disparities, and aligns incentives—critical as organizations like ACOs and health systems face financial risks.[1][2][6]
Market forces favoring Conduce included AI adoption in health tech (e.g., predictive modeling), demand for data-driven referrals, and payer pressures for cost-quality balance.[3][5][6] By influencing ecosystems through precision tools, it empowered providers to deliver holistic care at scale, paving the way for integrated platforms like post-acquisition Switchboard, which amplifies its impact in digital health networks.[2][3][7] Recognition like the 2025 New York Digital Health 100 underscored its role in New York's thriving health tech scene.[7]
Post-acquisition, Conduce's AI will supercharge Switchboard's platform, enabling broader adoption of predictive matching in referral workflows for health plans and systems.[2][3] Expect deeper integrations with EMRs, expanded virtual care, and refined models for emerging risks like advanced chronic cohorts, driven by trends in AI precision medicine and value-based mandates.[2][5][6]
Its influence will evolve from standalone innovator to core engine in scaled specialty networks, potentially setting standards for "high-value" care amid regulatory pushes for outcomes-based payments—transforming fragmented referrals into a unified, patient-first ecosystem, much like its founding mission to "conduce" better health.[1][4]
Conduce Health has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $3.0M Seed | Commerce Ventures, Connecticut Innovations, Convective Capital, Healthy Ventures, TY |